| Moderna Switzerland GmbH - Spikevax, Injektionsdispersion | | 68267 | | 01 | | Spikevax | | Injektionsdispersion | | J07BX03 | | Covid-19 Vaccines | | 12.01.2021 | | |
| | Composition | | elasomeranum 1.26 mg, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas, cholesterolum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus, trometamolum, trometamoli hydrochloridum, acidum aceticum, natrii acetas, saccharum, aqua ad iniectabile, ad suspensionem pro 6.3 ml corresp. natrium 0.033 mg pro dosi. | | Packungsbestandteile | | Injektionsdispersion | | | | | | Principe actif | Concentr. |
|---|
| Elasomeranum | 1.26mg / 6.3ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| 1,2-dimyristoyl-Rac-Glycero-3-Polyethylenglycoli | 2000 | | 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum | | | Acide Acétique | | | Aether Methylicus | | | Cholesterol | | | Sodium Acetate | | | Saccharum | | | Trometamoli Hydrochloridum | | | Trometamol | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 10 | DDP | DDP | B | | Oui |
|
|
